Successful treatment of recurrent visceral leishmaniasis relapse in an immunocompetent adult female with functional hypopituitarism in Bangladesh

Author:

Hannan Tabiha BinteORCID,Hossain Zazeba,Roy Utshab,Rahman S. M. Mahbubur,Rahman Md Sadiqur,Sabah Sadia,Rahat Md. Abu,Chowdhury Rajashree,Hossain Faria,Mondal Dinesh,Saha Shampa,Haq Tahniyah,Alam Md Rafiqul,Chowdhury Fazle Rabbi

Abstract

Background Currently available treatment options are mostly effective in achieving long-term cure in visceral leishmaniasis (VL) patients. However, there have been reports of recurrence of this illness in both immunosuppressed and immunocompetent patients. Case presentation We report the first case of recurrent VL relapse in a 19-year-old immunocompetent female with functional hypopituitarism (hypogonadotropic hypogonadism with central hypothyroidism) from Bangladesh, who has been treated three times previously with optimal dosage and duration- liposomal amphotericin B (LAmB) alone and in combination with miltefosine. We treated the patient successfully with a modified treatment regimen of 10 mg/kg body weight LAmB for two consecutive days along with oral miltefosine for seven days as loading dose. For secondary prophylaxis, the patient received 3 mg/kg body weight LAmB along with oral miltefosine for seven days monthly for five doses followed by hormonal replacement. The patient remained relapse free after 12 months of her treatment completion. Conclusion In the absence of protective vaccines against Leishmania species and standard treatment regimen, this modified treatment regimen could help the management of recurrent relapse cases.

Publisher

Public Library of Science (PLoS)

Reference12 articles.

1. World Health Organization (WHO). Global Health Observatory data on Leishmaniasis by category [Internet]. 2021. https://apps.who.int/gho/data/node.main.NTDLEISHVNUM?lang=en

2. World Health Organization (WHO). Global Leishmaniasis Surveillance by WHO [Internet]. 2021. https://www.who.int/publications/i/item/who-wer9745-575-590

3. Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy;A Mastroianni;AIDS Res Ther,2018

4. Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study;W Clemente;Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis,2015

5. Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection;H Sindermann;Clin Infect Dis an Off Publ Infect Dis Soc Am,2004

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Amphotericin-B-liposomal;Reactions Weekly;2024-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3